Home

valvola archivio Avviso mog igg lateralmente Sul punto cimasa

Neurological update: MOG antibody disease | SpringerLink
Neurological update: MOG antibody disease | SpringerLink

Corrected CSF/Serum MOG-IgG Index, Lesion Location, and Clinical... |  Download Scientific Diagram
Corrected CSF/Serum MOG-IgG Index, Lesion Location, and Clinical... | Download Scientific Diagram

Recent developments in MOG-IgG associated neurological disorders | Semantic  Scholar
Recent developments in MOG-IgG associated neurological disorders | Semantic Scholar

SensoLyte® Anti-Mouse MOG (1-125) IgG Quantitative ELISA Kit Colorimetric -  1 kit
SensoLyte® Anti-Mouse MOG (1-125) IgG Quantitative ELISA Kit Colorimetric - 1 kit

Detection of MOG-IgG by cell-based assay: moving from discovery to clinical  practice | SpringerLink
Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice | SpringerLink

Figure MRI of anti-MOG-IgG-associated myelitis | Download Scientific Diagram
Figure MRI of anti-MOG-IgG-associated myelitis | Download Scientific Diagram

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients.  Part 1: Frequency, syndrome specificity, influence of disease activity,  long-term course, association with AQP4-IgG, and origin – topic of research
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin – topic of research

Refining cell-based assay to detect MOG-IgG in patients with central  nervous system inflammatory diseases - ScienceDirect
Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases - ScienceDirect

MOG antibody disease: A review of MOG antibody seropositive neuromyelitis  optica spectrum disorder - ScienceDirect
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - ScienceDirect

Clinical Characteristics and Treatment of MOG-IgG–Associated Optic Neuritis  | SpringerLink
Clinical Characteristics and Treatment of MOG-IgG–Associated Optic Neuritis | SpringerLink

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain |  Acta Neuropathologica Communications | Full Text
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain | Acta Neuropathologica Communications | Full Text

Anti-MOG autoantibodies pathogenicity in children and macaques  demyelinating diseases | Journal of Neuroinflammation | Full Text
Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases | Journal of Neuroinflammation | Full Text

Beyond Aquaporin and MOG- Novel brain reactive antibodies and B cell  responses in Neuromyelitis optica spectrum disorders | Else  Kröner-Fresenius-Stiftung
Beyond Aquaporin and MOG- Novel brain reactive antibodies and B cell responses in Neuromyelitis optica spectrum disorders | Else Kröner-Fresenius-Stiftung

Vicente Martín on Twitter: "MOG in NMOSD Patients They have a different  immunopathogenic mechanism in MOG-IgG–positive Neuromyelitis Optica  Spectrum Disorders patients With some clinical, epidemiologic, and  radiologic features distinct from those in
Vicente Martín on Twitter: "MOG in NMOSD Patients They have a different immunopathogenic mechanism in MOG-IgG–positive Neuromyelitis Optica Spectrum Disorders patients With some clinical, epidemiologic, and radiologic features distinct from those in

Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated  Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS  Disorders?
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?

IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment  Approaches for NMOSD and MOGAD
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD

Diagnostic features of initial demyelinating events associated with serum  MOG-IgG - ScienceDirect
Diagnostic features of initial demyelinating events associated with serum MOG-IgG - ScienceDirect

Frontiers | Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD  Within a Real-World Cohort
Frontiers | Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort

Correlation of anti-MOG IgG concentration to disease disability in... |  Download Scientific Diagram
Correlation of anti-MOG IgG concentration to disease disability in... | Download Scientific Diagram

Brain Sciences | Free Full-Text | Coexistence of Myelin Oligodendrocyte  Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the  Central Nervous System: A Systematic Review
Brain Sciences | Free Full-Text | Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review

High titers of myelin oligodendrocyte glycoprotein antibody are only  observed close to clinical events in pediatrics - Multiple Sclerosis and  Related Disorders
High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics - Multiple Sclerosis and Related Disorders

Selective Depletion of Antigen-Specific Antibodies for the Treatment of  Demyelinating Disease - ScienceDirect
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease - ScienceDirect

The serum from a patient with human MOG-IgG shows a widespread... |  Download Scientific Diagram
The serum from a patient with human MOG-IgG shows a widespread... | Download Scientific Diagram

Frontiers | Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis  Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated  Disease
Frontiers | Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease

Frontiers | Age-Related Clinical Presentation of MOG-IgG Seropositivity in  Israel
Frontiers | Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel